3.25
price up icon1.14%   0.05
 
loading

Finanzdaten der Tharimmune Inc-Aktie (THAR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
27.31%
1.8512
2.5467 3.8475 3.8656 2.3735
Operating Income/Loss
27.31%
-1.8512
-2.5467 -3.8475 -3.8656 -2.3735
Nonoperating Income/Loss
180.42%
-0.00399
0.00497 0.0269 0.0697 0.0484
Income/Loss From Continuing Operations Before Tax
27.01%
-1.8552
-2.5417 -3.8206 -3.7959 -2.3251
Income/Loss From Continuing Operations After Tax
27.01%
-1.8552
-2.5417 -3.8206 -3.7959 -2.3251
Net Income/Loss
27.01%
-1.8552
-2.5417 -3.8206 -3.7959 -2.3251
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
11.84%
2.8773
2.5727 0.1631 1.5473 0.9621
Diluted Average Shares
11.84%
2.8773
2.5727 0.1631 1.5473 0.9621
Basic Earnings Per Share
35.35%
-0.64
-0.99 -2.02 -2.45 -2.42
Diluted Earnings Per Share
35.35%
-0.64
-0.99 -2.02 -2.45 -2.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.76
price up icon 1.24%
$28.93
price up icon 0.85%
$102.19
price up icon 0.70%
$104.59
price up icon 0.63%
biotechnology ONC
$311.51
price up icon 0.01%
$184.56
price down icon 0.84%
Kapitalisierung:     |  Volumen (24h):